AFP and gastric adenocarcinoma: Furthermore, since AFP-producing gastric adenocarcinoma is not homogeneous in terms of clinical outcome and molecular characteristics, it is critical to identify biomarkers that can further subcategorize AFP-producing gastric adenocarcinoma.